img

Global Oral Transmucosal Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Oral Transmucosal Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Oral Transmucosal Drugs
Oral Transmucosal Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Oral Transmucosal Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Cardiovascular Disorders and Acute Pain Managements are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Oral Transmucosal Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Oral Transmucosal Drugs key manufacturers include LTS Lohmann Therapie-Systeme AG, Soligenix, ZIM Laboratories Limited, Access Pharmaceutical Inc., C.L Pharm, Cure Pharmaceutical, Aquestive Therapeutics, Inc., NAL Pharma and IntelGenx Corp., etc. LTS Lohmann Therapie-Systeme AG, Soligenix, ZIM Laboratories Limited are top 3 players and held % sales share in total in 2022.
Oral Transmucosal Drugs can be divided into Tablets, Films, Liquid Spray and Gels, etc. Tablets is the mainstream product in the market, accounting for % sales share globally in 2022.
Oral Transmucosal Drugs is widely used in various fields, such as Cardiovascular Disorders, Acute Pain Managements, Diabetes and Others, etc. Cardiovascular Disorders provides greatest supports to the Oral Transmucosal Drugs industry development. In 2022, global % sales of Oral Transmucosal Drugs went into Cardiovascular Disorders filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oral Transmucosal Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


LTS Lohmann Therapie-Systeme AG
Soligenix
ZIM Laboratories Limited
Access Pharmaceutical Inc.
C.L Pharm
Cure Pharmaceutical
Aquestive Therapeutics, Inc.
NAL Pharma
IntelGenx Corp.
Eisai Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.
Teva Pharmaceutical Industries Ltd.
GlaxoSmithKline plc
Viatris
Bristol-Myers Squibb Company
Segment by Type
Tablets
Films
Liquid Spray
Gels
Others

Segment by Application


Cardiovascular Disorders
Acute Pain Managements
Diabetes
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Oral Transmucosal Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oral Transmucosal Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oral Transmucosal Drugs industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Oral Transmucosal Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oral Transmucosal Drugs introduction, etc. Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Oral Transmucosal Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Oral Transmucosal Drugs Market Overview
1.1 Oral Transmucosal Drugs Product Overview
1.2 Oral Transmucosal Drugs Market Segment by Type
1.2.1 Tablets
1.2.2 Films
1.2.3 Liquid Spray
1.2.4 Gels
1.2.5 Others
1.3 Global Oral Transmucosal Drugs Market Size by Type
1.3.1 Global Oral Transmucosal Drugs Market Size Overview by Type (2024-2034)
1.3.2 Global Oral Transmucosal Drugs Historic Market Size Review by Type (2024-2024)
1.3.3 Global Oral Transmucosal Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Oral Transmucosal Drugs Sales Breakdown by Type (2024-2024)
1.4.2 Europe Oral Transmucosal Drugs Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Oral Transmucosal Drugs Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Oral Transmucosal Drugs Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Oral Transmucosal Drugs Sales Breakdown by Type (2024-2024)
2 Global Oral Transmucosal Drugs Market Competition by Company
2.1 Global Top Players by Oral Transmucosal Drugs Sales (2024-2024)
2.2 Global Top Players by Oral Transmucosal Drugs Revenue (2024-2024)
2.3 Global Top Players by Oral Transmucosal Drugs Price (2024-2024)
2.4 Global Top Manufacturers Oral Transmucosal Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Oral Transmucosal Drugs Market Competitive Situation and Trends
2.5.1 Oral Transmucosal Drugs Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Oral Transmucosal Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Transmucosal Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Oral Transmucosal Drugs Market
2.8 Key Manufacturers Oral Transmucosal Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Oral Transmucosal Drugs Status and Outlook by Region
3.1 Global Oral Transmucosal Drugs Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Oral Transmucosal Drugs Historic Market Size by Region
3.2.1 Global Oral Transmucosal Drugs Sales in Volume by Region (2024-2024)
3.2.2 Global Oral Transmucosal Drugs Sales in Value by Region (2024-2024)
3.2.3 Global Oral Transmucosal Drugs Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Oral Transmucosal Drugs Forecasted Market Size by Region
3.3.1 Global Oral Transmucosal Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Oral Transmucosal Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Oral Transmucosal Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Oral Transmucosal Drugs by Application
4.1 Oral Transmucosal Drugs Market Segment by Application
4.1.1 Cardiovascular Disorders
4.1.2 Acute Pain Managements
4.1.3 Diabetes
4.1.4 Others
4.2 Global Oral Transmucosal Drugs Market Size by Application
4.2.1 Global Oral Transmucosal Drugs Market Size Overview by Application (2024-2034)
4.2.2 Global Oral Transmucosal Drugs Historic Market Size Review by Application (2024-2024)
4.2.3 Global Oral Transmucosal Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Oral Transmucosal Drugs Sales Breakdown by Application (2024-2024)
4.3.2 Europe Oral Transmucosal Drugs Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Oral Transmucosal Drugs Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Oral Transmucosal Drugs Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Oral Transmucosal Drugs Sales Breakdown by Application (2024-2024)
5 North America Oral Transmucosal Drugs by Country
5.1 North America Oral Transmucosal Drugs Historic Market Size by Country
5.1.1 North America Oral Transmucosal Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Oral Transmucosal Drugs Sales in Volume by Country (2024-2024)
5.1.3 North America Oral Transmucosal Drugs Sales in Value by Country (2024-2024)
5.2 North America Oral Transmucosal Drugs Forecasted Market Size by Country
5.2.1 North America Oral Transmucosal Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Oral Transmucosal Drugs Sales in Value by Country (2024-2034)
6 Europe Oral Transmucosal Drugs by Country
6.1 Europe Oral Transmucosal Drugs Historic Market Size by Country
6.1.1 Europe Oral Transmucosal Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Oral Transmucosal Drugs Sales in Volume by Country (2024-2024)
6.1.3 Europe Oral Transmucosal Drugs Sales in Value by Country (2024-2024)
6.2 Europe Oral Transmucosal Drugs Forecasted Market Size by Country
6.2.1 Europe Oral Transmucosal Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Oral Transmucosal Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Oral Transmucosal Drugs by Region
7.1 Asia-Pacific Oral Transmucosal Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Oral Transmucosal Drugs Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Oral Transmucosal Drugs Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Oral Transmucosal Drugs Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Oral Transmucosal Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Oral Transmucosal Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Oral Transmucosal Drugs Sales in Value by Region (2024-2034)
8 Latin America Oral Transmucosal Drugs by Country
8.1 Latin America Oral Transmucosal Drugs Historic Market Size by Country
8.1.1 Latin America Oral Transmucosal Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Oral Transmucosal Drugs Sales in Volume by Country (2024-2024)
8.1.3 Latin America Oral Transmucosal Drugs Sales in Value by Country (2024-2024)
8.2 Latin America Oral Transmucosal Drugs Forecasted Market Size by Country
8.2.1 Latin America Oral Transmucosal Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Oral Transmucosal Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Oral Transmucosal Drugs by Country
9.1 Middle East and Africa Oral Transmucosal Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Oral Transmucosal Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Oral Transmucosal Drugs Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Oral Transmucosal Drugs Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Oral Transmucosal Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Oral Transmucosal Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Oral Transmucosal Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 LTS Lohmann Therapie-Systeme AG
10.1.1 LTS Lohmann Therapie-Systeme AG Company Information
10.1.2 LTS Lohmann Therapie-Systeme AG Introduction and Business Overview
10.1.3 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2024-2024)
10.1.4 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Products Offered
10.1.5 LTS Lohmann Therapie-Systeme AG Recent Development
10.2 Soligenix
10.2.1 Soligenix Company Information
10.2.2 Soligenix Introduction and Business Overview
10.2.3 Soligenix Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Soligenix Oral Transmucosal Drugs Products Offered
10.2.5 Soligenix Recent Development
10.3 ZIM Laboratories Limited
10.3.1 ZIM Laboratories Limited Company Information
10.3.2 ZIM Laboratories Limited Introduction and Business Overview
10.3.3 ZIM Laboratories Limited Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2024-2024)
10.3.4 ZIM Laboratories Limited Oral Transmucosal Drugs Products Offered
10.3.5 ZIM Laboratories Limited Recent Development
10.4 Access Pharmaceutical Inc.
10.4.1 Access Pharmaceutical Inc. Company Information
10.4.2 Access Pharmaceutical Inc. Introduction and Business Overview
10.4.3 Access Pharmaceutical Inc. Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Access Pharmaceutical Inc. Oral Transmucosal Drugs Products Offered
10.4.5 Access Pharmaceutical Inc. Recent Development
10.5 C.L Pharm
10.5.1 C.L Pharm Company Information
10.5.2 C.L Pharm Introduction and Business Overview
10.5.3 C.L Pharm Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2024-2024)
10.5.4 C.L Pharm Oral Transmucosal Drugs Products Offered
10.5.5 C.L Pharm Recent Development
10.6 Cure Pharmaceutical
10.6.1 Cure Pharmaceutical Company Information
10.6.2 Cure Pharmaceutical Introduction and Business Overview
10.6.3 Cure Pharmaceutical Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Cure Pharmaceutical Oral Transmucosal Drugs Products Offered
10.6.5 Cure Pharmaceutical Recent Development
10.7 Aquestive Therapeutics, Inc.
10.7.1 Aquestive Therapeutics, Inc. Company Information
10.7.2 Aquestive Therapeutics, Inc. Introduction and Business Overview
10.7.3 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Products Offered
10.7.5 Aquestive Therapeutics, Inc. Recent Development
10.8 NAL Pharma
10.8.1 NAL Pharma Company Information
10.8.2 NAL Pharma Introduction and Business Overview
10.8.3 NAL Pharma Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2024-2024)
10.8.4 NAL Pharma Oral Transmucosal Drugs Products Offered
10.8.5 NAL Pharma Recent Development
10.9 IntelGenx Corp.
10.9.1 IntelGenx Corp. Company Information
10.9.2 IntelGenx Corp. Introduction and Business Overview
10.9.3 IntelGenx Corp. Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2024-2024)
10.9.4 IntelGenx Corp. Oral Transmucosal Drugs Products Offered
10.9.5 IntelGenx Corp. Recent Development
10.10 Eisai Co., Ltd.
10.10.1 Eisai Co., Ltd. Company Information
10.10.2 Eisai Co., Ltd. Introduction and Business Overview
10.10.3 Eisai Co., Ltd. Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Eisai Co., Ltd. Oral Transmucosal Drugs Products Offered
10.10.5 Eisai Co., Ltd. Recent Development
10.11 Otsuka Pharmaceutical Co., Ltd.
10.11.1 Otsuka Pharmaceutical Co., Ltd. Company Information
10.11.2 Otsuka Pharmaceutical Co., Ltd. Introduction and Business Overview
10.11.3 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Products Offered
10.11.5 Otsuka Pharmaceutical Co., Ltd. Recent Development
10.12 Teva Pharmaceutical Industries Ltd.
10.12.1 Teva Pharmaceutical Industries Ltd. Company Information
10.12.2 Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
10.12.3 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Products Offered
10.12.5 Teva Pharmaceutical Industries Ltd. Recent Development
10.13 GlaxoSmithKline plc
10.13.1 GlaxoSmithKline plc Company Information
10.13.2 GlaxoSmithKline plc Introduction and Business Overview
10.13.3 GlaxoSmithKline plc Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2024-2024)
10.13.4 GlaxoSmithKline plc Oral Transmucosal Drugs Products Offered
10.13.5 GlaxoSmithKline plc Recent Development
10.14 Viatris
10.14.1 Viatris Company Information
10.14.2 Viatris Introduction and Business Overview
10.14.3 Viatris Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Viatris Oral Transmucosal Drugs Products Offered
10.14.5 Viatris Recent Development
10.15 Bristol-Myers Squibb Company
10.15.1 Bristol-Myers Squibb Company Company Information
10.15.2 Bristol-Myers Squibb Company Introduction and Business Overview
10.15.3 Bristol-Myers Squibb Company Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Bristol-Myers Squibb Company Oral Transmucosal Drugs Products Offered
10.15.5 Bristol-Myers Squibb Company Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Oral Transmucosal Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Oral Transmucosal Drugs Industrial Chain Analysis
11.4 Oral Transmucosal Drugs Market Dynamics
11.4.1 Oral Transmucosal Drugs Industry Trends
11.4.2 Oral Transmucosal Drugs Market Drivers
11.4.3 Oral Transmucosal Drugs Market Challenges
11.4.4 Oral Transmucosal Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Oral Transmucosal Drugs Distributors
12.3 Oral Transmucosal Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Tablets
Table 2. Major Company of Films
Table 3. Major Company of Liquid Spray
Table 4. Major Company of Gels
Table 5. Major Company of Others
Table 6. Global Oral Transmucosal Drugs Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 7. Global Oral Transmucosal Drugs Sales by Type (2024-2024) & (K Units)
Table 8. Global Oral Transmucosal Drugs Sales Market Share in Volume by Type (2024-2024)
Table 9. Global Oral Transmucosal Drugs Sales by Type (2024-2024) & (US& Million)
Table 10. Global Oral Transmucosal Drugs Market Share in Value by Type (2024-2024)
Table 11. Global Oral Transmucosal Drugs Price by Type (2024-2024) & (US$/Unit)
Table 12. Global Oral Transmucosal Drugs Sales by Type (2024-2034) & (K Units)
Table 13. Global Oral Transmucosal Drugs Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Oral Transmucosal Drugs Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Oral Transmucosal Drugs Sales Market Share in Value by Type (2024-2034)
Table 16. Global Oral Transmucosal Drugs Price by Type (2024-2034) & (US$/Unit)
Table 17. North America Oral Transmucosal Drugs Sales by Type (2024-2024) & (K Units)
Table 18. North America Oral Transmucosal Drugs Sales by Type (2024-2024) & (US$ Million)
Table 19. Europe Oral Transmucosal Drugs Sales (K Units) by Type (2024-2024)
Table 20. Europe Oral Transmucosal Drugs Sales by Type (2024-2024) & (US$ Million)
Table 21. Asia-Pacific Oral Transmucosal Drugs Sales (K Units) by Type (2024-2024)
Table 22. Asia-Pacific Oral Transmucosal Drugs Sales by Type (2024-2024) & (US$ Million)
Table 23. Latin America Oral Transmucosal Drugs Sales (K Units) by Type (2024-2024)
Table 24. Latin America Oral Transmucosal Drugs Sales by Type (2024-2024) & (US$ Million)
Table 25. Middle East and Africa Oral Transmucosal Drugs Sales (K Units) by Type (2024-2024)
Table 26. Middle East and Africa Oral Transmucosal Drugs Sales by Type (2024-2024) & (US$ Million)
Table 27. Global Oral Transmucosal Drugs Sales by Company (2024-2024) & (K Units)
Table 28. Global Oral Transmucosal Drugs Sales Share by Company (2024-2024)
Table 29. Global Oral Transmucosal Drugs Revenue by Company (2024-2024) & (US$ Million)
Table 30. Global Oral Transmucosal Drugs Revenue Share by Company (2024-2024)
Table 31. Global Market Oral Transmucosal Drugs Price by Company (2024-2024) & (US$/Unit)
Table 32. Global Oral Transmucosal Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Oral Transmucosal Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Transmucosal Drugs as of 2022)
Table 35. Date of Key Manufacturers Enter into Oral Transmucosal Drugs Market
Table 36. Key Manufacturers Oral Transmucosal Drugs Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Oral Transmucosal Drugs Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 39. Global Oral Transmucosal Drugs Sales by Region (2024-2024) & (K Units)
Table 40. Global Oral Transmucosal Drugs Sales Market Share in Volume by Region (2024-2024)
Table 41. Global Oral Transmucosal Drugs Sales by Region (2024-2024) & (US$ Million)
Table 42. Global Oral Transmucosal Drugs Sales Market Share in Value by Region (2024-2024)
Table 43. Global Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 44. Global Oral Transmucosal Drugs Sales by Region (2024-2034) & (K Units)
Table 45. Global Oral Transmucosal Drugs Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Oral Transmucosal Drugs Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Oral Transmucosal Drugs Sales Market Share in Value by Region (2024-2034)
Table 48. Global Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 49. Global Oral Transmucosal Drugs Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 50. Global Oral Transmucosal Drugs Sales by Application (2024-2024) & (K Units)
Table 51. Global Oral Transmucosal Drugs Sales Market Share in Volume by Application (2024-2024)
Table 52. Global Oral Transmucosal Drugs Sales by Application (2024-2024) & (US$ Million)
Table 53. Global Oral Transmucosal Drugs Sales Market Share in Value by Application (2024-2024)
Table 54. Global Oral Transmucosal Drugs Price by Application (2024-2024) & (US$/Unit)
Table 55. Global Oral Transmucosal Drugs Sales by Application (2024-2034) & (K Units)
Table 56. Global Oral Transmucosal Drugs Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Oral Transmucosal Drugs Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Oral Transmucosal Drugs Sales Market Share in Value by Application (2024-2034)
Table 59. Global Oral Transmucosal Drugs Price by Application (2024-2034) & (US$/Unit)
Table 60. North America Oral Transmucosal Drugs Sales by Application (2024-2024) (K Units)
Table 61. North America Oral Transmucosal Drugs Sales by Application (2024-2024) & (US$ Million)
Table 62. Europe Oral Transmucosal Drugs Sales by Application (2024-2024) (K Units)
Table 63. Europe Oral Transmucosal Drugs Sales by Application (2024-2024) & (US$ Million)
Table 64. Asia-Pacific Oral Transmucosal Drugs Sales by Application (2024-2024) (K Units)
Table 65. Asia-Pacific Oral Transmucosal Drugs Sales by Application (2024-2024) & (US$ Million)
Table 66. Latin America Oral Transmucosal Drugs Sales by Application (2024-2024) (K Units)
Table 67. Latin America Oral Transmucosal Drugs Sales by Application (2024-2024) & (US$ Million)
Table 68. Middle East and Africa Oral Transmucosal Drugs Sales by Application (2024-2024) (K Units)
Table 69. Middle East and Africa Oral Transmucosal Drugs Sales by Application (2024-2024) & (US$ Million)
Table 70. North America Oral Transmucosal Drugs Sales by Country (2024-2024) & (K Units)
Table 71. North America Oral Transmucosal Drugs Sales Market Share in Volume by Country (2024-2024)
Table 72. North America Oral Transmucosal Drugs Sales by Country (2024-2024) & (US$ Million)
Table 73. North America Oral Transmucosal Drugs Sales Market Share in Value by Country (2024-2024)
Table 74. North America Oral Transmucosal Drugs Sales by Country (2024-2034) & (K Units)
Table 75. North America Oral Transmucosal Drugs Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Oral Transmucosal Drugs Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Oral Transmucosal Drugs Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Oral Transmucosal Drugs Sales by Country (2024-2024) & (K Units)
Table 79. Europe Oral Transmucosal Drugs Sales Market Share in Volume by Country (2024-2024)
Table 80. Europe Oral Transmucosal Drugs Sales by Country (2024-2024) & (US$ Million)
Table 81. Europe Oral Transmucosal Drugs Sales Market Share in Value by Country (2024-2024)
Table 82. Europe Oral Transmucosal Drugs Sales by Country (2024-2034) & (K Units)
Table 83. Europe Oral Transmucosal Drugs Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Oral Transmucosal Drugs Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Oral Transmucosal Drugs Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Oral Transmucosal Drugs Sales by Region (2024-2024) & (K Units)
Table 87. Asia-Pacific Oral Transmucosal Drugs Sales Market Share in Volume by Region (2024-2024)
Table 88. Asia-Pacific Oral Transmucosal Drugs Sales by Region (2024-2024) & (US$ Million)
Table 89. Asia-Pacific Oral Transmucosal Drugs Sales Market Share in Value by Region (2024-2024)
Table 90. Asia-Pacific Oral Transmucosal Drugs Sales by Region (2024-2034) & (K Units)
Table 91. Asia-Pacific Oral Transmucosal Drugs Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Oral Transmucosal Drugs Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Oral Transmucosal Drugs Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Oral Transmucosal Drugs Sales by Country (2024-2024) & (K Units)
Table 95. Latin America Oral Transmucosal Drugs Sales Market Share in Volume by Country (2024-2024)
Table 96. Latin America Oral Transmucosal Drugs Sales by Country (2024-2024) & (US$ Million)
Table 97. Latin America Oral Transmucosal Drugs Sales Market Share in Value by Country (2024-2024)
Table 98. Latin America Oral Transmucosal Drugs Sales by Country (2024-2034) & (K Units)
Table 99. Latin America Oral Transmucosal Drugs Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Oral Transmucosal Drugs Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Oral Transmucosal Drugs Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Oral Transmucosal Drugs Sales by Country (2024-2024) & (K Units)
Table 103. Middle East and Africa Oral Transmucosal Drugs Sales Market Share in Volume by Country (2024-2024)
Table 104. Middle East and Africa Oral Transmucosal Drugs Sales by Country (2024-2024) & (US$ Million)
Table 105. Middle East and Africa Oral Transmucosal Drugs Sales Market Share in Value by Country (2024-2024)
Table 106. Middle East and Africa Oral Transmucosal Drugs Sales by Country (2024-2034) & (K Units)
Table 107. Middle East and Africa Oral Transmucosal Drugs Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Oral Transmucosal Drugs Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Oral Transmucosal Drugs Sales Market Share in Value by Country (2024-2034)
Table 110. LTS Lohmann Therapie-Systeme AG Company Information
Table 111. LTS Lohmann Therapie-Systeme AG Introduction and Business Overview
Table 112. LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Product
Table 114. LTS Lohmann Therapie-Systeme AG Recent Development
Table 115. Soligenix Company Information
Table 116. Soligenix Introduction and Business Overview
Table 117. Soligenix Oral Transmucosal Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Soligenix Oral Transmucosal Drugs Product
Table 119. Soligenix Recent Development
Table 120. ZIM Laboratories Limited Company Information
Table 121. ZIM Laboratories Limited Introduction and Business Overview
Table 122. ZIM Laboratories Limited Oral Transmucosal Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. ZIM Laboratories Limited Oral Transmucosal Drugs Product
Table 124. ZIM Laboratories Limited Recent Development
Table 125. Access Pharmaceutical Inc. Company Information
Table 126. Access Pharmaceutical Inc. Introduction and Business Overview
Table 127. Access Pharmaceutical Inc. Oral Transmucosal Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. Access Pharmaceutical Inc. Oral Transmucosal Drugs Product
Table 129. Access Pharmaceutical Inc. Recent Development
Table 130. C.L Pharm Company Information
Table 131. C.L Pharm Introduction and Business Overview
Table 132. C.L Pharm Oral Transmucosal Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. C.L Pharm Oral Transmucosal Drugs Product
Table 134. C.L Pharm Recent Development
Table 135. Cure Pharmaceutical Company Information
Table 136. Cure Pharmaceutical Introduction and Business Overview
Table 137. Cure Pharmaceutical Oral Transmucosal Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. Cure Pharmaceutical Oral Transmucosal Drugs Product
Table 139. Cure Pharmaceutical Recent Development
Table 140. Aquestive Therapeutics, Inc. Company Information
Table 141. Aquestive Therapeutics, Inc. Introduction and Business Overview
Table 142. Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 143. Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Product
Table 144. Aquestive Therapeutics, Inc. Recent Development
Table 145. NAL Pharma Company Information
Table 146. NAL Pharma Introduction and Business Overview
Table 147. NAL Pharma Oral Transmucosal Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 148. NAL Pharma Oral Transmucosal Drugs Product
Table 149. NAL Pharma Recent Development
Table 150. IntelGenx Corp. Company Information
Table 151. IntelGenx Corp. Introduction and Business Overview
Table 152. IntelGenx Corp. Oral Transmucosal Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 153. IntelGenx Corp. Oral Transmucosal Drugs Product
Table 154. IntelGenx Corp. Recent Development
Table 155. Eisai Co., Ltd. Company Information
Table 156. Eisai Co., Ltd. Introduction and Business Overview
Table 157. Eisai Co., Ltd. Oral Transmucosal Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 158. Eisai Co., Ltd. Oral Transmucosal Drugs Product
Table 159. Eisai Co., Ltd. Recent Development
Table 160. Otsuka Pharmaceutical Co., Ltd. Company Information
Table 161. Otsuka Pharmaceutical Co., Ltd. Introduction and Business Overview
Table 162. Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 163. Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Product
Table 164. Otsuka Pharmaceutical Co., Ltd. Recent Development
Table 165. Teva Pharmaceutical Industries Ltd. Company Information
Table 166. Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
Table 167. Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 168. Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Product
Table 169. Teva Pharmaceutical Industries Ltd. Recent Development
Table 170. GlaxoSmithKline plc Company Information
Table 171. GlaxoSmithKline plc Introduction and Business Overview
Table 172. GlaxoSmithKline plc Oral Transmucosal Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 173. GlaxoSmithKline plc Oral Transmucosal Drugs Product
Table 174. GlaxoSmithKline plc Recent Development
Table 175. Viatris Company Information
Table 176. Viatris Introduction and Business Overview
Table 177. Viatris Oral Transmucosal Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 178. Viatris Oral Transmucosal Drugs Product
Table 179. Viatris Recent Development
Table 180. Bristol-Myers Squibb Company Company Information
Table 181. Bristol-Myers Squibb Company Introduction and Business Overview
Table 182. Bristol-Myers Squibb Company Oral Transmucosal Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 183. Bristol-Myers Squibb Company Oral Transmucosal Drugs Product
Table 184. Bristol-Myers Squibb Company Recent Development
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Oral Transmucosal Drugs Market Trends
Table 188. Oral Transmucosal Drugs Market Drivers
Table 189. Oral Transmucosal Drugs Market Challenges
Table 190. Oral Transmucosal Drugs Market Restraints
Table 191. Oral Transmucosal Drugs Distributors List
Table 192. Oral Transmucosal Drugs Downstream Customers
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Transmucosal Drugs Product Picture
Figure 2. Global Oral Transmucosal Drugs Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Oral Transmucosal Drugs Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Oral Transmucosal Drugs Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Tablets
Figure 6. Global Tablets Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Films
Figure 8. Global Films Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Liquid Spray
Figure 10. Global Liquid Spray Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Gels
Figure 12. Global Gels Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 15. Global Oral Transmucosal Drugs Sales by Type (2024-2034) & (US$ Million)
Figure 16. Global Oral Transmucosal Drugs Sales Market Share by Type in 2022 & 2034
Figure 17. North America Oral Transmucosal Drugs Sales Market Share in Volume by Type in 2022
Figure 18. North America Oral Transmucosal Drugs Sales Market Share in Value by Type in 2022
Figure 19. Europe Oral Transmucosal Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Europe Oral Transmucosal Drugs Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Oral Transmucosal Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Oral Transmucosal Drugs Sales Market Share in Value by Type in 2022
Figure 23. Latin America Oral Transmucosal Drugs Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Oral Transmucosal Drugs Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Oral Transmucosal Drugs Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Oral Transmucosal Drugs Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Transmucosal Drugs Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Transmucosal Drugs Revenue in 2022
Figure 29. Oral Transmucosal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 30. Product Picture of Cardiovascular Disorders
Figure 31. Global Cardiovascular Disorders Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Acute Pain Managements
Figure 33. Global Acute Pain Managements Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Product Picture of Diabetes
Figure 35. Global Diabetes Sales YoY Growth (2024-2034) & (K Units)
Figure 36. Product Picture of Others
Figure 37. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 38. Global Oral Transmucosal Drugs Sales by Application (2024-2034) & (US$ Million)
Figure 39. Global Oral Transmucosal Drugs Sales Market Share by Application in 2022 & 2034
Figure 40. North America Oral Transmucosal Drugs Sales Market Share in Volume by Application in 2022
Figure 41. North America Oral Transmucosal Drugs Sales Market Share in Value by Application in 2022
Figure 42. Europe Oral Transmucosal Drugs Sales Market Share in Volume by Application in 2022
Figure 43. Europe Oral Transmucosal Drugs Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Oral Transmucosal Drugs Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Oral Transmucosal Drugs Sales Market Share in Value by Application in 2022
Figure 46. Latin America Oral Transmucosal Drugs Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Oral Transmucosal Drugs Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Oral Transmucosal Drugs Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Oral Transmucosal Drugs Manufacturing Cost Structure
Figure 51. Oral Transmucosal Drugs Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries